These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3812217)

  • 1. Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase.
    Lew AS; Hod H; Cercek B; Shah PK; Ganz W
    Am J Cardiol; 1987 Jan; 59(1):1-5. PubMed ID: 3812217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous streptokinase in acute myocardial infarction. Reduction of early in-hospital mortality].
    Cortadellas J; Figueras J; Curos A; Cinca J; Moya A; Angel J; Salas A; Roma F
    Rev Esp Cardiol; 1989 Apr; 42(4):254-61. PubMed ID: 2781119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.
    Battershill PE; Benfield P; Goa KL
    Drugs Aging; 1994 Jan; 4(1):63-86. PubMed ID: 8130384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction].
    Acar J; Dorent R; Vahanian A; Michel PL; Cormier B; Slama M; Cazaux P; Conard J; Verdy E; Samama M
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():59-65. PubMed ID: 3142430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical development of the in-hospital phase of acute myocardial infarction in patients treated with intravenous streptokinase].
    Frutos E; Verdejo J; Morales E; Martínez-Ríos MA; Cárdenas M
    Arch Inst Cardiol Mex; 1990; 60(3):289-93. PubMed ID: 2241403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting outcome of coronary reperfusion with intracoronary streptokinase in acute myocardial infarction.
    Smalling RW; Fuentes F; Matthews MW; Kuhn J; Nishikawa A; Walker WE; Adams PR; Gould KL
    Am J Cardiol; 1987 Mar; 59(6):505-12. PubMed ID: 3548299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy in acute myocardial infarction in Pakistan.
    Karim MA; Mahmood SF; Akhter J; Qureshi AR
    J Pak Med Assoc; 1995 Mar; 45(3):54-8. PubMed ID: 7596011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
    Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U
    Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous streptokinase in acute evolving myocardial infarction--six to thirty-six months follow up.
    Chopra KL; Chopra HK; Aggarwal KK
    Indian Heart J; 1990; 42(1):13-25. PubMed ID: 2190912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis and myocardial infarction.
    Rovelli F; Mauri F; Roghi A
    Biomed Pharmacother; 1987; 41(8):417-20. PubMed ID: 3330456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of intraaortic balloon counterpulsation and streptokinase in acute anterior myocardial infarction.
    Kumbasar SD; Semiz E; Sancaktar O; Yalçinkaya S; Ermiş C; Değer N
    Angiology; 1999 Jun; 50(6):465-71. PubMed ID: 10378822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cardiac rupture following streptokinase in patients with acute myocardial infarction: retrospective cohort study.
    Polić S; Perković D; Stula I; Punda A; Lukin A; Rumboldt Z
    Croat Med J; 2000 Sep; 41(3):303-5. PubMed ID: 10962050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind trial of intravenous streptokinase for acute myocardial infarction.
    Schreiber TL; Miller DH; Silvasi DA; Moses JW; Borer JS
    Am J Cardiol; 1986 Jul; 58(1):47-52. PubMed ID: 3524182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.
    Goa KL; Henwood JM; Stolz JF; Langley MS; Clissold SP
    Drugs; 1990 May; 39(5):693-719. PubMed ID: 2191849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].
    Steffensen R; Sandøe E
    Ugeskr Laeger; 1991 Oct; 153(41):2880-3. PubMed ID: 1949301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous streptokinase in acute myocardial infarction (I.S.A.M.): assessment of left ventricular function 1 and 7 months after infarction by radionuclide ventriculography.
    Voth E; Tebbe U; Schicha H; Neumann P; Schröder R; Neuhaus KL; Emrich D
    Eur Heart J; 1990 Oct; 11(10):885-96. PubMed ID: 2265640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.